Awa. Baltzer et al., A gene therapy approach to accelerating bone healing - Evaluation of gene expression in a New Zealand white rabbit model, KNEE SURG S, 7(3), 1999, pp. 197-202
It has been demonstrated that BMPs, IGFs, and TGF beta s improve the proces
s of bone healing in vivo. We have suggested the use of gene therapy as a p
ossible way to deliver growth factors to fracture sites in order to improve
repair. The aim of this study was to develop a minimally invasive gene the
rapy approach to treat bone injuries locally without damaging the local blo
od circulation. A segmental defect of 1.3 cm was created in the diaphysis o
f the femur in mature NZW rabbits. Internal fixation with 7-hole DCP plates
and 2.7 mm screws was used to stabilize the bone. After building a chamber
by tightly closing the muscles around the segmental defect, 0.5 mi of eith
er saline solution or a collagen gel containing 1 x 10(10) particles of ade
novirus carrying cDNA encoding either the bacterial beta-galactosidase gene
(LacZ), or the firefly luciferase gene were injected into the gap. The con
trol side received 0.5 ml of saline solution without virus particles. Bone
marrow, cortical and trabecular bone and surrounding muscle were harvested
from the injected femur and were analyzed for local gene expression through
X-gal staining or measurement of local luciferase activity. To determine w
hether distant sites were transduced, tissue from the spleen. liver, and lu
ng were harvested as well as bone, bone marrow and muscle from the contrala
teral diaphysis of the femur. The delivery of the adenoviral vector suspend
ed in saline solution led to local transduction of the bone, bone marrow an
d the muscle surrounding the gap. No luciferase activity was found in the c
ontralateral femur, lung, or spleen, and only transient luciferase activity
was seen in the liver. While marker gene expression persisted within the s
urrounding soft tissues for at least 2 weeks, the expression in bone lasted
up to 6 weeks. This study has shown that it is possible to use adenoviral
vectors to transfer and express genes locally within a segmental defect. Ge
ne expression persisted for several weeks, which may be already sufficient
to accelerate repair.